apis india & china
DESCRIPTION
APIs India & China. Dr. Brian W Tempest www.briantempest.com March 2009 Bangladesh. Chinese DMFs. Indian DMFs now >50%. Indian DMFs versus All DMFs. DMFs for New Molecules. Indian DMFs - 1. Indian DMFs -2. Indian DMFs -3. Indian DMFs - 4. Indian DMF Niches. In Summary. - PowerPoint PPT PresentationTRANSCRIPT
Hale & Tempest
APIs India & China
Dr. Brian W Tempest
www.briantempest.com
March 2009 Bangladesh
Hale & Tempest
Chinese DMFs
Hale & Tempest
Indian DMFs now >50%
Hale & Tempest
Indian DMFs versus All DMFs
Hale & Tempest
DMFs for New Molecules
Hale & Tempest
Indian DMFs - 1
Hale & Tempest
Indian DMFs -2
Hale & Tempest
Indian DMFs -3
Hale & Tempest
Indian DMFs - 4
Hale & Tempest
Indian DMF Niches
Hale & Tempest
In Summary
•4Q08 DMFs filed with FDA represent 51% of all filings for the first time. Q308 was 43%
•China DMFs now represents only 8%
•23 new molecules have seen Indian filings - leading to a total filing from India now of 398 molecules. $3.1b sales
•The big cap Indian companies are taking a smaller share in new filings
•The number of molecules with more than 5 Indian filings has risen to 82 from 75 in Q308
Hale & Tempest
Thank You